Abstract
The critical care and perioperative settings are high consumers of blood products, with multiple units and different products often given to an individual patient. The recommendation of this review is always to consider the risks and benefits for a specific blood product for a specific patient in a specific clinical setting. Optimize patient status by treating anemia and preventing the need for red blood cell transfusion. Consider other options for correction of anemia and coagulation disorders and use an imperative non-overtransfusion policy for all blood products.
Original language | English |
---|---|
Journal | Critical Care Clinics |
Volume | 34 |
Issue number | 2 |
Pages (from-to) | 299-311 |
Number of pages | 13 |
ISSN | 0749-0704 |
DOIs | |
Publication status | Published - 2018 |
Keywords
- Anemia
- Critical care
- ICU
- Perioperative
- Plasma
- Platelets
- Red blood cells
- Thrombocytes